General Information |
|
Product |
CD19 Peptide |
Description |
Antigenic Blocking Peptide B-lymphocyte antigen CD19 Antibody |
Verified Applications |
Immmunodepletion, Competition Assay |
Peptide Description |
Synthetic peptide taken within amino acid region 200-250 on human CD19 protein. |
Accession # |
NCBI: AAB60697 |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Overview |
Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor dependent stimulation |
Molecular Function |
Receptor Signaling protein activity |
Subcellular Location |
Membrane; Single-pass type I membrane protein. |
Structure |
Contains 2 Ig-like C2-type domains. |
Alternative Nomenclature |
Antibody deficiency due to defect in CD19, included antibody AW495831 antibody CVID3 antibody Leu 12 antibody Lymphocyte Surface Antigen antibody T-cell surface antigen Leu-12 antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
CD19-101AP | |||
|
CD19-FITC | |||
|
CD19-BIOTIN | |||
|
PC-CD19 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.